Pearl River Fisheries Research Institute, CAFS, Key Laboratory of Aquatic Animal Drug Development, MOA, NO.1 Xingyu Road, Guangzhou 510380, PR China.
Fish Shellfish Immunol. 2012 Oct;33(4):880-5. doi: 10.1016/j.fsi.2012.07.012. Epub 2012 Aug 21.
Infectious spleen and kidney necrosis virus (ISKNV) is the causative agent of a disease causing high mortality and economic losses in mandarin fish, Siniperca chuatsi in China. But little information about vaccine development against ISKNV disease is available. In this study the gene encoding the major capsid protein (MCP), which is predominant structural component of the iridovirus particles, was cloned into a temperature induction prokaryotic expression vector pBV220 and a recombinant protein was detected about 50 kDa in molecular weight and accounted for 23% of total proteins of whole cell. Polyclonal antibodies were raised in rabbits against the purified protein and the reaction of the antibody was confirmed by western blotting using the purified protein and the spleen and kidney of healthy and diseased mandarin fish. The recombinant protein was renatured by dialysis and the juvenile mandarin fish were vaccinated by intraperitoneal injection with recombinant MCP emulsified with ISA 763 adjuvant at a dose of 20 μg/fish, 50 μg/fish and 100 μg/fish, respectively. Specific antibodies and lymphocyte proliferation were detected in three groups and the values of MCP50 group were higher than the other two groups. After challenge infection with ISKNV, fish of MCP50 group showed significantly greater survival than the others and the RPS was 64.3%. In conclusion, the humoral immunity and cellar immunity of mandarin fish were induced by recombinant MCP and the best immune dose was 50 μg/fish. To the best of our knowledge, this is the first time that a recombinant protein vaccine against ISKNV disease was developed in mandarin fish.
传染性脾肾坏死病毒(ISKNV)是导致中国鳜鱼(Siniperca chuatsi)高死亡率和经济损失的病原体。但针对 ISKNV 病的疫苗开发信息较少。在这项研究中,主要衣壳蛋白(MCP)的基因被克隆到温度诱导的原核表达载体 pBV220 中,该蛋白是虹彩病毒粒子的主要结构成分,分子量约为 50 kDa,占全细胞总蛋白的 23%。用纯化蛋白和健康及患病鳜鱼的脾脏和肾脏制备多克隆抗体,并通过 Western blot 对抗体反应进行确认。通过透析对重组蛋白进行复性,并用 ISA 763 佐剂将重组 MCP 乳化后,通过腹腔注射对幼鳜鱼进行免疫接种,剂量分别为 20μg/鱼、50μg/鱼和 100μg/鱼。在三组中检测到特异性抗体和淋巴细胞增殖,MCP50 组的值高于其他两组。用 ISKNV 进行攻毒感染后,MCP50 组的鱼存活率明显高于其他组,RPS 为 64.3%。总之,重组 MCP 诱导了鳜鱼的体液免疫和细胞免疫,最佳免疫剂量为 50μg/鱼。据我们所知,这是首次在鳜鱼中开发针对 ISKNV 病的重组蛋白疫苗。